Results From the CEPHEUS Clinical Trial of Daratumumab Combination Therapy in Newly Diagnosed Multiple Myeloma by Madaline Spencer| Published on: Jun 25, 2026

Results From the CEPHEUS Clinical Trial of Daratumumab Combination Therapy in Newly Diagnosed Multiple Myeloma by Madaline Spencer| Published on: Jun 25, 2026 Saad Usmani, MD, Hematologist-Oncologist at Memorial Sloan Kettering Cancer Center, discusses results from the CEPHEUS clinical trial of daratumumab combination therapy in patients with newly diagnosed multiple myeloma (MM). https://checkrare.com/results-from-the-cepheus-clinical-trial-of-daratumumab-combination-therapy-in-newly-diagnosed-multiple-myeloma/

Oral Deucrictibant for On-Demand Treatment of Hereditary Angioedema Attacks by Madaline Spencer| Published on: Jun 25, 2026

Oral Deucrictibant for On-Demand Treatment of Hereditary Angioedema Attacks by Madaline Spencer| Published on: Jun 25, 2026 A study published in The Lancet Hematology evaluated the efficacy and safety of deucrictibant for the on-demand treatment of hereditary angioedema (HAE) attacks. https://checkrare.com/oral-deucrictibant-for-on-demand-treatment-of-hereditary-angioedema-attacks/

Long-Term Results of Ziftomenib Combination Therapy in Patients With Acute Myeloid Leukemia by Madaline Spencer| Published on: Jun 26, 2026

Long-Term Results of Ziftomenib Combination Therapy in Patients With Acute Myeloid Leukemia by Madaline Spencer| Published on: Jun 26, 2026 Eunice S. Wang, MD, Chief of Leukemia at Roswell Park Comprehensive Cancer Center, discusses long-term results of ziftomenib in combination with venetoclax and azacitidine in patients with acute myeloid leukemia (AML). https://checkrare.com/long-term-results-of-ziftomenib-combination-therapy-in-patients-with-acute-myeloid-leukemia/

The COVID Vaccine Study the CDC Doesn’t Want You to See F. Perry Wilson, MD, MSCE

https://www.medscape.com/viewarticle/covid-vaccine-study-cdc-doesnt-want-you-see-2026a1000l3b?ecd=WNL_trdalrt_pos1_ous_260626_etid8455600&uac=148436CN&impID=8455600

Guideline Summaries CKM Syndrome: ACC/AHA/ADA/ASN 2026 Guideline Summary +...

https://reference.medscape.com/guidelines Guideline Summaries https://reference.medscape.com/c26/p14/guideline-summaries-2026a10007cb

Newborn Resuscitation and Support of Transition of Infants at Birth Source: Resuscitation Council UK

https://reference.medscape.com/cc2/p10/rcuk-guideline-newborn-resuscitation-and-support-2026a1000gt0?ecd=WNL_drugguide_260626_MSCPREF_idhiv_etid8450288&uac=148436CN&impID=8450288 This Medscape guideline summary covers recommendations by the Resuscitation Council UK on how to support newborn transition and perform resuscitation at birth, including preparation, assessment, interventions, and post-resuscitation care. It applies to both hospital and out-of-hospital settings (especially when there is an unexpected and/or preterm birth). For information on background, rationale and objectives, target audience, scope of the recommendations, and persons affected by them, refer to the full RCUK guideline. A list of abbreviations can be found at the end of this summary.

Blood Transfusion Source: National Institute for Health and Care Excellence

https://reference.medscape.com/cc2/p10/nice-blood-transfusion-guideline-2026a1000gal?ecd=WNL_drugguide_260626_MSCPREF_idhiv_etid8450288&uac=148436CN&impID=8450288 Latest Guidance Updates February 2026: The evidence was reviewed, and new recommendations were made on using tranexamic acid during surgery.